These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 203191)

  • 1. Converting enzyme, angiotensin II and hypertensive disease.
    Soffer RL; Case DB
    Am J Med; 1978 Jan; 64(1):147-160. PubMed ID: 203191
    [No Abstract]   [Full Text] [Related]  

  • 2. Estimating renin participation in hypertension: superiority of converting enzyme inhibitor over saralasin.
    Case DB; Wallace JM; Keim HJ; Weber MA; Drayer JI; White RP; Sealey JE; Laragh JH
    Am J Med; 1976 Nov; 61(5):790-6. PubMed ID: 185903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The renin/angiotensin system.
    Lee MR
    Br J Clin Pharmacol; 1981 Nov; 12(5):605-12. PubMed ID: 6174135
    [No Abstract]   [Full Text] [Related]  

  • 4. Renin lowers blood-pressure.
    Gordon DB
    Lancet; 1978 Nov; 2(8097):970-2. PubMed ID: 81992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The tonin-angiotensin II system].
    Boucher R; Demassieux S; Garcia R; Gutkowska Y; Genest J
    Union Med Can; 1977 Apr; 106(4):502-7. PubMed ID: 193229
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical implications of renin in the hypertensive patient.
    Brunner HR; Gavras H
    JAMA; 1975 Sep; 233(10):1091-3. PubMed ID: 1174160
    [No Abstract]   [Full Text] [Related]  

  • 7. Blood pressure response of nephrectomized hypertensive rats to converting enzyme inhibition: evidence for persistent vascular renin activity.
    Thurston H; Swales JD
    Clin Sci Mol Med; 1977 Mar; 52(3):299-304. PubMed ID: 844262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitors of the renin-angiotensin system in experimental hypertension, with a note on the measurement of angiotensin I, II and III during infusion of converting-enzyme inhibitor.
    Morton JJ; Casals-Stenzel J; Lever AF; Millar JA; Riegger AJ; Tree M
    Br J Clin Pharmacol; 1979; 7 Suppl 2(Suppl 2):233S-241S. PubMed ID: 223615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in responses to bradykinin, angiotensin I, and angiotensin II during the induction phase of one-kidney, one-wrapped hypertension and associated arterial disease in rabbits.
    Campbell WG; Donohue JA; Duket LH
    Am J Pathol; 1980 Feb; 98(2):457-84. PubMed ID: 6243872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The immediate pressor response to saralasin: a measure of the degree of angiotensin II vascular receptor vacancy.
    Wallace JM; Case DB; Laragh JH; Sealey JE; Keim HJ; Drayer JI
    Trans Assoc Am Physicians; 1977; 90():300-12. PubMed ID: 205983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renin-angiotensin system in hypertension.
    Swales JD
    Pharmacol Ther; 1979; 7(1):173-201. PubMed ID: 230525
    [No Abstract]   [Full Text] [Related]  

  • 12. Reversal by angiotensins II and III of the effects of converting enzyme inhibition on renal electrolyte excretion in rats.
    Harris PJ; Munro JO
    J Physiol; 1984 Jun; 351():491-500. PubMed ID: 6205144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison between saralsin and converting enzyme inhibitor in hypertensive disease.
    Case DB; Wallace JM; Laragh JH
    Kidney Int Suppl; 1979 Mar; (9):S107-114. PubMed ID: 225598
    [No Abstract]   [Full Text] [Related]  

  • 14. Angiotensin as a renal, adrenal, and cardiovascular hormone: responses to saralasin in normal man and in essential and secondary hypertension.
    Hollenberg NK; Williams GH
    Kidney Int Suppl; 1979 Mar; (9):S29-35. PubMed ID: 384070
    [No Abstract]   [Full Text] [Related]  

  • 15. Is there a brain renin-angiotensin system?
    Reid IA
    Circ Res; 1977 Aug; 41(2):147-53. PubMed ID: 194727
    [No Abstract]   [Full Text] [Related]  

  • 16. The second Volhard Lecture: The use of blocking agents to define the functions of the renin--angiotensin system.
    Davis JO
    Clin Sci Mol Med Suppl; 1975 Jun; 2():3s-14s. PubMed ID: 802643
    [No Abstract]   [Full Text] [Related]  

  • 17. Endocrine mechanisms in the pathogenesis of essential hypertension. VI. Blockade of the renin-angiotensin system as a therapeutical basis.
    Păuşescu E
    Physiologie; 1982; 19(4):245-64. PubMed ID: 6185963
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of intracerebroventricular administration of tonin on water intake and blood pressure in the rat.
    Kondo K; Garcia R; Boucher R; Genest J
    Brain Res; 1980 Nov; 200(2):437-41. PubMed ID: 6158365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockade of renin or angiotensin for understanding human hypertension: a comparison of propranolol, saralasin and converting enzyme blockade.
    Laragh JH; Case DB; Wallace JM; Keim H
    Fed Proc; 1977 Apr; 36(5):1781-7. PubMed ID: 191300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrarenal effects of the renin-angiotensin system.
    Ploth DW; Navar LG
    Fed Proc; 1979 Aug; 38(9):2280-5. PubMed ID: 456614
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.